Enovis (ENOV) EBT (2010 - 2026)

Enovis (ENOV) has reported EBT for 17 consecutive years, with $7.5 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBT rose 129.1% year-over-year to $7.5 million in Q3 2026; TTM through Jul 2026 was -$1.1 billion, a 33.65% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 40.89% from the prior year.
• EBT was $7.5 million for Q3 2026 at Enovis, up from $634000.0 in the prior quarter.
• Over five years, EBT peaked at $116.4 million in Q3 2022 and troughed at -$673.7 million in Q4 2024.
• A 5-year average of -$113.5 million and a median of -$28.7 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT surged 401.46% in 2023 and tumbled 8898.82% in 2024, its largest moves.
• Over 5 years, EBT stood at -$2.5 million in 2022, then surged by 401.46% to $7.7 million in 2023, then plunged by 8898.82% to -$673.7 million in 2024, then rose by 24.37% to -$509.5 million in 2025, then surged by 101.47% to $7.5 million in 2026.
• The last three EBT figures came in at $7.5 million (Q3 2026), $634000.0 (Q2 2026), and -$509.5 million (Q4 2025), per Business Quant data.